Alembic Pharmaceuticals Limited (NSE:APLLTD)

Alembic Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	149,437	130,370	182,755	193,575	97,564	145,771
Market Cap Growth	-18.50%	-28.66%	-5.59%	98.41%	-33.07%	-23.15%
Enterprise Value	161,715	143,795	192,124	200,785	104,548	151,109
Last Close Price	781.30	653.53	906.05	949.00	473.08	696.10

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	21.55	19.32	31.33	31.43	28.53	27.98
Forward PE	19.43	16.15	25.37	28.71	19.15	19.76
PS Ratio	1.97	1.78	2.74	3.11	1.73	2.75
PB Ratio	2.71	2.30	3.52	4.02	2.23	2.78
P/TBV Ratio	2.85	2.42	3.52	4.02	2.23	2.87
P/FCF Ratio	44.12	37.45	-	40.69	34.78	115.04
P/OCF Ratio	19.62	16.66	207.75	24.10	13.48	26.39
PEG Ratio	1.30	0.66	1.13	1.09	1.89	3.25

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	2.13	1.96	2.88	3.22	1.85	2.85
EV/EBITDA Ratio	14.38	13.10	19.42	21.97	15.02	17.60
EV/EBIT Ratio	20.11	18.04	26.33	30.39	23.88	25.72
EV/FCF Ratio	47.64	41.31	-	42.21	37.27	119.26

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.25	0.25	0.24	0.11	0.17	0.14
Debt / EBITDA Ratio	1.24	1.28	1.25	0.55	1.01	0.82
Debt / FCF Ratio	-	4.11	-	1.08	2.57	5.66
Net Debt / Equity Ratio	0.22	0.22	0.23	0.08	0.15	0.13
Net Debt / EBITDA Ratio	1.09	1.12	1.19	0.43	0.93	0.76
Net Debt / FCF Ratio	-	3.54	-2.47	0.83	2.31	5.18
Asset Turnover	-	0.89	0.94	0.99	0.85	0.77
Inventory Turnover	-	0.87	0.96	1.15	1.15	0.97
Quick Ratio	-	0.65	0.62	0.82	0.74	0.52
Current Ratio	-	1.76	1.70	2.12	1.78	1.67
Return on Equity (ROE)	-	12.36%	11.63%	13.40%	7.12%	10.11%
Return on Assets (ROA)	-	6.02%	6.42%	6.54%	4.11%	5.31%
Return on Invested Capital (ROIC)	11.34%	11.62%	10.38%	12.59%	7.74%	8.69%
Return on Capital Employed (ROCE)	-	12.90%	13.60%	13.20%	9.60%	10.90%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	4.64%	5.18%	3.19%	3.18%	3.50%	3.57%
FCF Yield	2.27%	2.67%	-2.60%	2.46%	2.88%	0.87%
Dividend Yield	1.58%	1.81%	1.18%	1.12%	1.61%	1.35%
Payout Ratio	34.01%	32.04%	37.06%	25.54%	57.48%	52.83%
Buyback Yield / Dilution	-0.04%	-	-	-	-	-1.46%
Total Shareholder Return	1.55%	1.81%	1.18%	1.12%	1.61%	-0.11%

Data Source: S&P Global Market Intelligence Last updated: Aug 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error